Among the most pressing yet overlooked public health challenges of our time is the stigma experienced by patients living with incurable or terminal illness, particularly those with advanced cancer. As populations age and cancer survival improves, a growing number of individuals are navigating life's final chapter within healthcare systems historically designed around cure. I have become deeply passionate about this issue because it sits at an intersection that is rarely named: the harm caused not by disease, but by the way we talk about dying. Patients with terminal cancer already carry enormous burdens—unrelenting symptoms, difficult treatment decisions, and the psychological weight of mortality. Yet many also report feeling devalued within the very systems meant to care for them. Qualitative research reveals patients overhearing clinicians say things like "there is nothing more we can do" or encountering their care described as "just comfort care"—language they interpret as a signal that their lives no longer warrant investment. They describe being reduced to a prognosis, labeled dismissively as a "palliative case," or noticing a subtle but unmistakable shift in how providers engage with them once their disease becomes incurable. These are not isolated experiences. They reflect a systemic pattern in which biomedical culture equates aggressive treatment with good care, and frames comfort-focused choices as "giving up." Patients who choose quality of life over curative intervention can find themselves morally judged, positioned as less deserving of attentive, dignified care. What makes this a public health issue, not simply an interpersonal or clinical one, is the downstream harm these communication patterns generate at scale. When patients sense devaluation, they disengage. They stop disclosing symptoms, avoid asking questions, and delay or forgo palliative care services that could meaningfully improve their remaining time. Internalized stigma compounds this: patients who absorb the implicit message that they are a burden may experience heightened shame that affects sleep, appetite, pain perception, and adherence to the care they do accept. At the population level, stigmatizing communication contributes to poorer mental health outcomes—depression, anxiety, existential distress—as well as complicated grief among families and increased costs from fragmented, poorly coordinated end-of-life care. I sincerely care about this problem for both intellectual and human reasons. Intellectually, it occupies a fascinating and underexplored space in the literature. Cancer-related stigma has received significant scholarly attention, but most research focuses on earlier stages of illness, survivorship, or public fear of a cancer diagnosis. Far less is known about how stigma operates specifically in end-of-life communication, where terms like "do not resuscitate" or "no further active treatment" carry potent symbolic weight. Understanding how language constructs meaning in these moments, and how it might be changed, is both a research gap and an urgent practical need. Humanly, this issue matters because everyone will eventually be a patient at the end of life, and everyone deserves to be treated with dignity in that moment. Communication that emphasizes ongoing goals of care, shared decision-making, and continued support can actively disrupt stigmatizing narratives. The words clinicians choose are not neutral; rather, they either affirm or erode a patient's sense of worth at their most vulnerable. The evidence base on how to address communication-related stigma in end-of-life oncology remains fragmented. Existing communication training programs rarely frame language as a stigma mechanism, and direct interventions designed to reduce provider-driven stigma in this population are scarce. Closing that gap—through rigorous research, thoughtful practice change, and structural reform—is work I am committed to pursuing. Because how we treat people at the end of their lives is a measure of who we are as a healthcare system, and as a society.